Literature DB >> 8708018

The prevalence of hidradenitis suppurativa and its potential precursor lesions.

G B Jemec1, M Heidenheim, N H Nielsen.   

Abstract

BACKGROUND: The morbidity of hidradenitis suppurativa can be considerable, but little is known about its epidemiology.
OBJECTIVE: Our purpose was to describe the 1-year and point prevalences of hidradenitis suppurativa and its potential precursor lesions.
METHODS: We obtained the histories and examined an unselected sample (599 persons) of the general population (1-year prevalence), and we performed physical examinations for a consecutive sample of 507 persons undergoing screening for sexually transmitted diseases (point prevalence).
RESULTS: The point prevalence was 4.1% (95% confidence interval [CI] = 3.0-6.0) on the basis of objective findings. The 1-year prevalence of hidradenitis was 1.0% (CI = 0.4-2.2) on the basis of subject recollection only. The patients in the sample on which point prevalence is based were younger than those in the unselected sample of the general population (p < 0.001). Hidradenitis was significantly more common in women (p = 0.037), which may result from a female preponderance of genitofemoral lesions (odds ratio [OR] = 5.4; CI = 1.5 - 19.3). No sex difference was found in the prevalence of axillary lesions.
CONCLUSION: Hidradenitis suppurativa is significantly more common than hitherto estimated. The female preponderance of patients is confirmed, except for patients with axillary lesions. Additional longitudinal studies are necessary to assess the importance of potential precursor lesions such as noninflamed nodules or comedones.

Entities:  

Mesh:

Year:  1996        PMID: 8708018     DOI: 10.1016/s0190-9622(96)90321-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  87 in total

1.  [Acne inversa].

Authors:  A Stein; G Sebastian
Journal:  Hautarzt       Date:  2003-02       Impact factor: 0.751

2.  [Treatment of pilonidal sinus and acne inversa].

Authors:  H Breuninger
Journal:  Hautarzt       Date:  2004-03       Impact factor: 0.751

Review 3.  [Surgical management of acne inversa].

Authors:  G Weyandt
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

4.  [Acne inversa].

Authors:  F G Bechara; W Hartschuh
Journal:  Hautarzt       Date:  2010-01       Impact factor: 0.751

5.  Comorbidities of hidradenitis suppurativa (acne inversa).

Authors:  Sabine Fimmel; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2010-01

Review 6.  Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.

Authors:  Nicolò Scuderi; Ambra Monfrecola; Luca Andrea Dessy; Gabriella Fabbrocini; Matteo Megna; Giuseppe Monfrecola
Journal:  Skin Appendage Disord       Date:  2017-03-21

7.  Characteristics of inflammatory eye disease associated with hidradenitis suppurativa.

Authors:  Didem Saygın; Abrahim U Syed; Careen Y Lowder; Sunil Srivastava; Juan J Maya; Rula A Hajj-Ali
Journal:  Eur J Rheumatol       Date:  2018-06-22

8.  The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.

Authors:  George Denny; Milan J Anadkat
Journal:  J Am Acad Dermatol       Date:  2016-09-28       Impact factor: 11.527

9.  A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa.

Authors:  Robert A Lee; Erica Dommasch; James Treat; Joslyn Sciacca-Kirby; Samuel Chachkin; Jennifer Williams; Daniel B Shin; James J Leyden; Carmela Vittorio; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2009-01-31       Impact factor: 11.527

10.  Successful Treatment of Recalcitrant Hidradenitis Suppurativa with Adalimumab.

Authors:  Ian Gorovoy; Adar Berghoff; Laura Ferris
Journal:  Case Rep Dermatol       Date:  2009-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.